Profusa Inc (PFSA)

$1.25 -0.60 (-32.43%)
Market Cap 2.52M
Revenue (ttm) 0.00
Net Income (ttm) -8.71M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.59
Volume 8,606,500
Avg Vol 5,639,357
Day's Range N/A - N/A
Shares Out 1.36M
Stochastic %K 45%
Beta 0.28
Analysts Strong Buy
Price Target N/A

Company Profile

Profusa, Inc. develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.

Industry: Medical Devices
Sector: Healthcare
Phone: 925 997 6925
Website: profusa.com
Address:
626 Bancroft Way, Suite A, Berkeley, United States
_TannerPicks
_TannerPicks Apr. 8 at 1:04 PM
$ATPC $ANY.X $UGRO $PFSA l
0 · Reply
TannerPicks
TannerPicks Apr. 8 at 12:25 PM
$QUBT $PFSA $BAC $LYB §§§§§
0 · Reply
Nrvisions
Nrvisions Apr. 8 at 10:46 AM
$PFSA Buy the dip 🚀
0 · Reply
jeni1988
jeni1988 Apr. 8 at 9:13 AM
$PFSA Back to reality , when real stocks are up, shit stocks are down
0 · Reply
Joby099
Joby099 Apr. 8 at 9:06 AM
$PFSA
0 · Reply
_SupermanTrdez
_SupermanTrdez Apr. 8 at 4:47 AM
Keep a close watch on CYCU ✅ News this morning and plus got a $7 dollar buy rating! -Cybersecurity is becoming mandatory infrastructure and CYCU is right in the middle of it. -While the world is dealing with rising cyber threats, this company is building backlog and contracts. Add in short pressure and you’ve got serious squeeze potential if volume steps in. With markets heating up CYCU can be a big runner! $GPUS $PFSA $PRFX $TGHL nice /./.
0 · Reply
BestNwest
BestNwest Apr. 8 at 4:41 AM
$PFSA buy signal maybe momentum to 3$ soon
0 · Reply
stockid
stockid Apr. 8 at 3:24 AM
$PFSA next swing candidate. Good acquisition story.
0 · Reply
Z_interceptor
Z_interceptor Apr. 8 at 12:41 AM
$PFSA [ Im not done shorting this !!! Will continue AGAIN ! ]
0 · Reply
ShadowSnake
ShadowSnake Apr. 8 at 12:15 AM
$PFSA
0 · Reply
Latest News on PFSA
Profusa Expands into Multi-Billion Dollar Precision Diagnostics Market with $30M Letter of Intent for a PanOmics Platform

Apr 6, 2026, 6:00 AM EDT - 2 days ago

Profusa Expands into Multi-Billion Dollar Precision Diagnostics Market with $30M Letter of Intent for a PanOmics Platform

Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering

Feb 27, 2026, 9:15 AM EST - 5 weeks ago

Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering

Profusa Receives Purchase Orders for Lumee™ Tissue Oxygen Monitoring and Raises 2026 Revenue Guidance

Feb 19, 2026, 8:30 AM EST - 6 weeks ago

Profusa Receives Purchase Orders for Lumee™ Tissue Oxygen Monitoring and Raises 2026 Revenue Guidance

Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies

Feb 13, 2026, 8:30 AM EST - 7 weeks ago

Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies

Profusa Announces 1-for-75 Reverse Stock Split

Feb 5, 2026, 8:00 AM EST - 2 months ago

Profusa Announces 1-for-75 Reverse Stock Split

Profusa Presents Positive US-Study Clinical Results at Leipzig Interventional Course (LINC) 2026

Jan 29, 2026, 8:00 AM EST - 2 months ago

Profusa Presents Positive US-Study Clinical Results at Leipzig Interventional Course (LINC) 2026

Profusa Stock Spikes As Lumee System Targets Research Market

Jan 16, 2026, 12:51 PM EST - 2 months ago

Profusa Stock Spikes As Lumee System Targets Research Market

Profusa Launches Lumee™ Tissue Oxygen Healthcare Research Offerings, Initiating First Commercial Revenue

Jan 16, 2026, 7:30 AM EST - 2 months ago

Profusa Launches Lumee™ Tissue Oxygen Healthcare Research Offerings, Initiating First Commercial Revenue

Profusa Adds Leading Greek Vascular Surgeon to Customer Base

Jan 8, 2026, 7:30 AM EST - 3 months ago

Profusa Adds Leading Greek Vascular Surgeon to Customer Base

Profusa Bolsters European Commercial Network with New French Distributor, MedSell

Dec 31, 2025, 7:30 AM EST - 3 months ago

Profusa Bolsters European Commercial Network with New French Distributor, MedSell

Profusa Stock Soars—To 12 Cents—On Debt Restructuring

Dec 30, 2025, 4:22 PM EST - 3 months ago

Profusa Stock Soars—To 12 Cents—On Debt Restructuring

Profusa Restructures Senior Secured Convertible Notes, Only Convertible Above $0.35

Dec 30, 2025, 7:30 AM EST - 3 months ago

Profusa Restructures Senior Secured Convertible Notes, Only Convertible Above $0.35

Profusa U.S. Study Met Primary End Points as Presented at Late Breaking Clinical Trials at Paris Vascular Insights 2025

Dec 15, 2025, 7:30 AM EST - 4 months ago

Profusa U.S. Study Met Primary End Points as Presented at Late Breaking Clinical Trials at Paris Vascular Insights 2025

Profusa to Present US-Study Clinical Data at Leipzig Interventional Course (LINC) 2026

Dec 11, 2025, 8:30 AM EST - 4 months ago

Profusa to Present US-Study Clinical Data at Leipzig Interventional Course (LINC) 2026

Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025

Nov 24, 2025, 8:15 AM EST - 4 months ago

Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025

Profusa Announces Third Quarter Business and Financial Highlights

Nov 19, 2025, 5:44 PM EST - 4 months ago

Profusa Announces Third Quarter Business and Financial Highlights

Profusa Outlines Potential Path to $250 Million Revenue by 2030, Driven by Sequential Lumee™ Oxygen and Glucose Monitoring Launches

Oct 30, 2025, 7:30 AM EDT - 5 months ago

Profusa Outlines Potential Path to $250 Million Revenue by 2030, Driven by Sequential Lumee™ Oxygen and Glucose Monitoring Launches

Profusa Completes Manufacturing Build-Out, On Track to Begin Product Shipments and Revenue in Early 2026

Oct 28, 2025, 8:30 AM EDT - 5 months ago

Profusa Completes Manufacturing Build-Out, On Track to Begin Product Shipments and Revenue in Early 2026

Profusa Expands Sales Footprint with New Distributor for Lumee™ Oxygen Platform in Europe

Oct 22, 2025, 8:30 AM EDT - 6 months ago

Profusa Expands Sales Footprint with New Distributor for Lumee™ Oxygen Platform in Europe

Profusa Invests Additional $1 Million in Digital Treasury Assets

Oct 7, 2025, 8:15 AM EDT - 6 months ago

Profusa Invests Additional $1 Million in Digital Treasury Assets

Profusa Adds a Leading French Critical Limb Ischemia Surgeon to Customer Base

Oct 1, 2025, 8:30 AM EDT - 6 months ago

Profusa Adds a Leading French Critical Limb Ischemia Surgeon to Customer Base

Profusa Adopts NVIDIA-Powered Technology to Build AI-Driven Insight Portal for Continuous Biomarker Monitoring

Sep 11, 2025, 8:30 AM EDT - 7 months ago

Profusa Adopts NVIDIA-Powered Technology to Build AI-Driven Insight Portal for Continuous Biomarker Monitoring

Profusa Adds Head of Vascular Surgery Department at AZ Sint Blasius Hospital, Belgium to Growing Customer Base

Sep 4, 2025, 8:30 AM EDT - 7 months ago

Profusa Adds Head of Vascular Surgery Department at AZ Sint Blasius Hospital, Belgium to Growing Customer Base

Profusa Announces Commercial and Clinical Collaboration with Head of Angiography, Medical University of Graz, Austria

Aug 27, 2025, 8:45 AM EDT - 8 months ago

Profusa Announces Commercial and Clinical Collaboration with Head of Angiography, Medical University of Graz, Austria

Profusa Welcomes Former Acting U.S. Veterans Affairs Secretary Peter O'Rourke as Lead Independent Director; Adds Seasoned Finance Executive Fred Knechtel as CFO

Aug 19, 2025, 8:15 AM EDT - 8 months ago

Profusa Welcomes Former Acting U.S. Veterans Affairs Secretary Peter O'Rourke as Lead Independent Director; Adds Seasoned Finance Executive Fred Knechtel as CFO

Profusa, Inc. Provides Strategy Overview and Business Update for Investors

Aug 6, 2025, 8:15 AM EDT - 8 months ago

Profusa, Inc. Provides Strategy Overview and Business Update for Investors

Profusa Secures Lumee™ Oxygen Platform Distributor in Spain

Jul 31, 2025, 8:15 AM EDT - 8 months ago

Profusa Secures Lumee™ Oxygen Platform Distributor in Spain

Profusa Announces $100 Million Equity Line of Credit to Initiate Bitcoin Treasury Strategy

Jul 21, 2025, 8:00 AM EDT - 9 months ago

Profusa Announces $100 Million Equity Line of Credit to Initiate Bitcoin Treasury Strategy

Profusa Announces Closing of Business Combination and the Commencement of Trading on Nasdaq

Jul 11, 2025, 4:00 PM EDT - 9 months ago

Profusa Announces Closing of Business Combination and the Commencement of Trading on Nasdaq

_TannerPicks
_TannerPicks Apr. 8 at 1:04 PM
$ATPC $ANY.X $UGRO $PFSA l
0 · Reply
TannerPicks
TannerPicks Apr. 8 at 12:25 PM
$QUBT $PFSA $BAC $LYB §§§§§
0 · Reply
Nrvisions
Nrvisions Apr. 8 at 10:46 AM
$PFSA Buy the dip 🚀
0 · Reply
jeni1988
jeni1988 Apr. 8 at 9:13 AM
$PFSA Back to reality , when real stocks are up, shit stocks are down
0 · Reply
Joby099
Joby099 Apr. 8 at 9:06 AM
$PFSA
0 · Reply
_SupermanTrdez
_SupermanTrdez Apr. 8 at 4:47 AM
Keep a close watch on CYCU ✅ News this morning and plus got a $7 dollar buy rating! -Cybersecurity is becoming mandatory infrastructure and CYCU is right in the middle of it. -While the world is dealing with rising cyber threats, this company is building backlog and contracts. Add in short pressure and you’ve got serious squeeze potential if volume steps in. With markets heating up CYCU can be a big runner! $GPUS $PFSA $PRFX $TGHL nice /./.
0 · Reply
BestNwest
BestNwest Apr. 8 at 4:41 AM
$PFSA buy signal maybe momentum to 3$ soon
0 · Reply
stockid
stockid Apr. 8 at 3:24 AM
$PFSA next swing candidate. Good acquisition story.
0 · Reply
Z_interceptor
Z_interceptor Apr. 8 at 12:41 AM
$PFSA [ Im not done shorting this !!! Will continue AGAIN ! ]
0 · Reply
ShadowSnake
ShadowSnake Apr. 8 at 12:15 AM
$PFSA
0 · Reply
GregRiskTaker
GregRiskTaker Apr. 7 at 9:54 PM
$PFSA I waited all afternoon to get in at this low price, I got 6780 shares at $1.22 Lets Ride!
0 · Reply
Penny_Stonk_Scalper
Penny_Stonk_Scalper Apr. 7 at 9:47 PM
$PFSA got a feeling this will gap fill the $6 then exercise then do an offering. Getting in while it’s low.
0 · Reply
Natalie777
Natalie777 Apr. 7 at 8:54 PM
$PFSA on break today. The next RUN should be STRONGER.
0 · Reply
Joby099
Joby099 Apr. 7 at 8:35 PM
$PFSA
0 · Reply
Z_interceptor
Z_interceptor Apr. 7 at 8:05 PM
$PFSA - Target is 0.30
1 · Reply
ShadowSnake
ShadowSnake Apr. 7 at 7:57 PM
$PFSA AH news would be great…
0 · Reply
ggabel7
ggabel7 Apr. 7 at 7:14 PM
hehehe 😂 just like covid 🍊 was trying to down play and booha disruption. Iran have one powerful card in hand it’s the strait i have been patiently adding every dip here $TPET undervalued and heavy shorts interest TPET atm 20 millions in hand and working to get a few additional small oil companies..:.run to 250 when oil was at 94 stay tuned thx gawd from $AIXI $HCAI $PFSA and $UVIX going to TPET not greedy 35k shares average .70 just need 3
0 · Reply
STLHD
STLHD Apr. 7 at 6:25 PM
$PFSA Low float 1.14-1.4 mil. Projected to announce next quarterly results towards end of month but the official date hasn't been announced.
0 · Reply
ShadowSnake
ShadowSnake Apr. 7 at 6:20 PM
$PFSA slow climb to $2+ is just as good as a huge spike…
0 · Reply
RonBoy3
RonBoy3 Apr. 7 at 6:00 PM
$PFSA Webull tells me that there’s an earning report due soon…?
0 · Reply
No_Face_character
No_Face_character Apr. 7 at 5:51 PM
$AIXI $MGRT $FCUV $SMX $PFSA not spam, just noting the difference between those that pop and continue vs. those that pop but flame out. unreal.
1 · Reply
Goldwave9
Goldwave9 Apr. 7 at 5:47 PM
$PFSA yes, the road back is long, but as sure as the night follows the day, we will be right back where we were and beyond ...all it takes is the patience of a gnat.
0 · Reply